ERBITUX
Google image searchProduct monograph
Active ingredient
cetuximab, 2 MG/ML
DIN: 02271249
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription / Schedule D
Company: IMCLONE, LLC
Date: 30-APR-2010
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FE — EGFR (Epidermal Growth Factor Receptor) inhibitors (ATC, ATC/DDD)
- L01FE01 — CETUXIMAB (ATC/DDD)
Reference brand drug: Erbitux
